- Over 70% – 41 million of total 56 million global deaths are due to noncommunicable diseases (NCDs) with significant differences by countries and regions.
| Related Megatrends: Inequality; Consumerism; Geopower
- Noncommunicable conditions are projected to account for 52 million death in 2030, representing some 75% of all deaths — up from 63% (36 million people) in 2013 and 71% (41 million people) in 2016.
| Related Megatrends: Demography; Inequality; Consumerism; Geopower;
- Four groups of diseases account for over 80% of all premature NCD deaths: 1. cardiovascular diseases (17.9 million people annually); 2. cancers (9.0 million); respiratory diseases (3.9million); and diabetes (1.6 million) and are expected to remain so given lifestyle paterns and aging population. | Related Megatrends: Consumerism; Geopower; Inequality
- 80% of premature heart disease, stroke and diabetes could be prevented.
- Cancer is the second leading cause of death globally, caucusing nearly 1 in 6 death. The number of new cases is expected to rise by about 70% over the next 2 decades;
- Global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014 (some 422 million people) and WHO projects that diabetes might be the 7th leading cause of death in 2030.
- More than 85% of the ‘premature’ deaths due to NCD occur in low and middle-income countries. | Related Megatrend: Inequality;
- In many low-income countries, communicable diseases make up the greatest component of the total disease burden, and the management of communicable diseases signifies an important challenge for health systems.
- The largest increases in NCD deaths will probably occur in Africa due to the rise of the middle class.
| Related Megatrends: Inequality; Demography; Consumerism
- Ageing of populations in low- and middle-income countries will result in significant increase of total deaths due to NCDs.
| Related Megatrends: Demography; Inequality
Goal 3 "Ensure healthy lives and promote well-being for all at all ages" of the SDGs includes two targets directly related to noncommunicable diseases.
90% of all health R&D expenditure is targeted at problems that affect only 10% of the world’s population.| Related Megatrends: Inequalities; TechnologyAbout 20% of health expenditure makes...